Moolec Science Statistics
Total Valuation
Moolec Science has a market cap or net worth of $50.49 million. The enterprise value is $61.34 million.
| Market Cap | 50.49M |
| Enterprise Value | 61.34M |
Important Dates
The next estimated earnings date is Tuesday, June 18, 2024, before market open.
| Earnings Date | Jun 18, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Moolec Science has 37.56 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Shares Outstanding | 37.56M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 80.28% |
| Owned by Institutions (%) | 0.03% |
| Float | 14.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.93 |
| Forward PS | 32.74 |
| PB Ratio | 8.21 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 21.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.43, with a Debt / Equity ratio of 1.25.
| Current Ratio | 0.43 |
| Quick Ratio | 1.51 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.09 |
Financial Efficiency
Return on equity (ROE) is -69.60% and return on invested capital (ROIC) is -58.59%.
| Return on Equity (ROE) | -69.60% |
| Return on Assets (ROA) | -29.50% |
| Return on Capital (ROIC) | -58.59% |
| Revenue Per Employee | $64,383 |
| Profits Per Employee | -$144,025 |
| Employee Count | 45 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -685,823 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.81% in the last 52 weeks. The beta is -0.47, so Moolec Science's price volatility has been lower than the market average.
| Beta (1Y) | -0.47 |
| 52-Week Price Change | -57.81% |
| 50-Day Moving Average | 1.54 |
| 200-Day Moving Average | 2.41 |
| Relative Strength Index (RSI) | 47.15 |
| Average Volume (30 Days) | 1,421,061 |
Short Selling Information
The latest short interest is 5,118, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 5,118 |
| Short Previous Month | 14,192 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 0.40 |
Income Statement
In the last 12 months, Moolec Science had revenue of $2.90 million and -$6.48 million in losses. Loss per share was -$0.13.
| Revenue | 2.90M |
| Gross Profit | 309,177 |
| Operating Income | -8.80M |
| Pretax Income | -7.17M |
| Net Income | -6.48M |
| EBITDA | -6.25M |
| EBIT | -6.81M |
| Loss Per Share | -$0.13 |
Balance Sheet
The company has $1.83 million in cash and $8.33 million in debt, giving a net cash position of -$6.50 million or -$0.17 per share.
| Cash & Cash Equivalents | 1.83M |
| Total Debt | 8.33M |
| Net Cash | -6.50M |
| Net Cash Per Share | -$0.17 |
| Equity / Book Value | 6.68M |
| Book Value Per Share | 0.18 |
| Working Capital | -4.73M |
Cash Flow
In the last 12 months, operating cash flow was -$12.58 million and capital expenditures -$111,745, giving a free cash flow of -$12.69 million.
| Operating Cash Flow | -12.58M |
| Capital Expenditures | -111,745 |
| Free Cash Flow | -12.69M |
| FCF Per Share | -$0.34 |
Margins
Gross margin is 10.67%, with operating and profit margins of -303.74% and -223.70%.
| Gross Margin | 10.67% |
| Operating Margin | -303.74% |
| Pretax Margin | -247.37% |
| Profit Margin | -223.70% |
| EBITDA Margin | -215.65% |
| EBIT Margin | -235.06% |
| FCF Margin | -437.94% |
Dividends & Yields
Moolec Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
| Earnings Yield | -11.82% |
| FCF Yield | -23.13% |
Analyst Forecast
The average price target for Moolec Science is $6.00, which is 344.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 344.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 64.76% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Jan 3, 2023 |
| Split Type | n/a |
| Split Ratio | 1:1 |
Scores
Moolec Science has an Altman Z-Score of -3.01 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.01 |
| Piotroski F-Score | 1 |